Most people who have cancer cells in their bones don't have primary bone cancer. They have cancer cells that have spread into the bone from a cancer elsewhere in the body. This is called secondary or ...

Benefits of Combining Circulating Tumor DNA With Tissue and Longitudinal Circulating Tumor DNA Genotyping in Advanced Solid Tumors: SCRUM-Japan MONSTAR-SCREEN-1 Study Osteosarcoma (OS) is the most ...

SON-1010, an engineered interleukin-12 cytokine, aims to activate the immune system to target tumor cells in sarcoma patients. The SB101 trial's Safety Review Committee found no unexpected toxicities ...

Shanghai Key Laboratory of Advanced Polymeric Materials, School of Materials Science and Engineering, East China University of Science and Technology, Shanghai 200237, China ...

OST-HER2 is an immunotherapy for osteosarcoma using a HER2 bioengineered form of the bacteria Listeria monocytogenes to trigger a strong immune response against cancer cells expressing HER2.

In this study we evaluated the immunohistochemical expression of ferritinophagy-related proteins, namely Ferritin Heavy chain (FTH1) and NCOA4, and proliferating cell nuclear antigen (PCNA) in canine ...

1 Department of Orthopedics, Central Hospital Affiliated to Shandong First Medical University, Jinan, China 2 Laboratory Medicine, Central Hospital Affiliated to Shandong First Medical University, ...

Consider for a moment the blue whale. Weighing up to 200 tons, this majestic creature is believed to be the largest animal that has ever existed on planet Earth. It also has a remarkably long lifespan ...